Vascular Endothelial–Cadherin Tyrosine Phosphorylation in Angiogenic and Quiescent Adult Tissues
- 18 February 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 96 (3), 384-391
- https://doi.org/10.1161/01.res.0000156652.99586.9f
Abstract
Vascular endothelial–cadherin (VE-cadherin) plays a key role in angiogenesis and in vascular permeability. The regulation of its biological activity may be a central mechanism in normal or pathological angiogenesis. VE-cadherin has been shown to be phosphorylated on tyrosine in vitro under various conditions, including stimulation by VEGF. In the present study, we addressed the question of the existence of a tyrosine phosphorylated form of VE-cadherin in vivo, in correlation with the quiescent versus angiogenic state of adult tissues. Phosphorylated VE-cadherin was detected in mouse lung, uterus, and ovary but not in other tissues unless mice were injected with peroxovanadate to block protein phosphatases. Remarkably, VE-cadherin tyrosine phosphorylation was dramatically increased in uterus and ovary, and not in other organs, during PMSG/hCG-induced angiogenesis. In parallel, we observed an increased association of VE-cadherin with Flk1 (VEGF receptor 2) during hormonal angiogenesis. Additionally, Src kinase was constitutively associated with VE-cadherin in both quiescent and angiogenic tissues and increased phosphorylation of VE-cadherin–associated Src was detected in uterus and ovary after hormonal treatment. Src-VE-cadherin association was detected in cultured endothelial cells, independent of VE-cadherin phosphorylation state and Src activation level. In this model, Src inhibition impaired VEGF-induced VE-cadherin phosphorylation, indicating that VE-cadherin phosphorylation was dependent on Src activation. We conclude that VE-cadherin is a substrate for tyrosine kinases in vivo and that its phosphorylation, together with that of associated Src, is increased by angiogenic stimulation. Physical association between Flk1, Src, and VE-cadherin may thus provide an efficient mechanism for amplification and perpetuation of VEGF-stimulated angiogenic processes.Keywords
This publication has 62 references indexed in Scilit:
- NADPH oxidase mediates vascular endothelial cadherin phosphorylation and endothelial dysfunctionBlood, 2004
- Vascular Endothelial Growth Factor Induces Shc Association With Vascular Endothelial CadherinArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Tyrosine Phosphatases SHP-1 and SHP-2 Are Associated with Distinct Tyrosine-Phosphorylated ProteinsExperimental Cell Research, 2002
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Association of Human Protein-tyrosine Phosphatase κ with Members of the Armadillo FamilyPublished by Elsevier BV ,1996
- Protein-tyrosine Phosphatase-mediated Decrease of Epidermal Growth Factor and Platelet-derived Growth Factor Receptor Tyrosine Phosphorylation in High Cell Density CulturesPublished by Elsevier BV ,1996
- Thrombin-Induced Increase in Endothelial Permeability Is Associated With Changes in Cell-to-Cell Junction OrganizationArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Functional Properties of Human Vascular Endothelial Cadherin (7B4/Cadherin-5), an Endothelium-Specific CadherinArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene.The Journal of cell biology, 1993
- Protein Tyrosine Phosphatases: A Diverse Family of Intracellular and Transmembrane EnzymesScience, 1991